
Research compound
KLOW
£66.00/ 80mg vial
Four-peptide research blend, 80 mg
KLOW is a combined research preparation named for its four components: KPV, the anti-inflammatory tripeptide fragment of alpha-MSH; the copper tripeptide GHK-Cu; the actin-binding thymosin fragment TB-500; and BPC-157. It is supplied as a single 80 mg lyophilised vial for laboratories investigating these compounds in combination.
Each batch is manufactured in the UK and released against independent HPLC and mass-spectrometry analysis. Because the vial contains four distinct peptides, the certificate reports each component separately.
The blend is used in preclinical and in-vitro models where repair, inflammation and matrix-remodelling pathways are studied together. Laboratory research use only.
Order before 3pm for same-day UK dispatch on Royal Mail Tracked 24, from £4.99.
Independent testing
All lab reportsHPLC and mass spectrometry on every batch. Certificate of Analysis available on request.
Third-party analysis by Janoshik Analytical. Each certificate is verifiable on the laboratory’s own site.
- Manufactured and lyophilised in the UK
- Plain, tracked packaging from £4.99
- For laboratory research use only
Research Handling Guidance
Before reconstitution, allow both the lyophilised peptide and your chosen diluent to settle at normal laboratory room temperature. Equalising temperatures in this way supports the structural stability of the compound while it goes into solution.
Diluents and reconstitution solutions are purchased separately.